Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Receivables - Net (2016 - 2025)

Historic Receivables - Net for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $2.0 million.

  • InspireMD's Receivables - Net rose 2816.99% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 2816.99%. This contributed to the annual value of $1.6 million for FY2024, which is 1286.03% down from last year.
  • According to the latest figures from Q3 2025, InspireMD's Receivables - Net is $2.0 million, which was up 2816.99% from $1.6 million recorded in Q2 2025.
  • Over the past 5 years, InspireMD's Receivables - Net peaked at $2.0 million during Q3 2025, and registered a low of $708000.0 during Q1 2021.
  • Its 5-year average for Receivables - Net is $1.3 million, with a median of $1.2 million in 2021.
  • The largest annual percentage gain for InspireMD's Receivables - Net in the last 5 years was 15714.29% (2021), contrasted with its biggest fall of 1728.97% (2021).
  • InspireMD's Receivables - Net (Quarter) stood at $1.2 million in 2021, then dropped by 15.52% to $1.0 million in 2022, then surged by 74.47% to $1.8 million in 2023, then decreased by 12.86% to $1.6 million in 2024, then increased by 24.75% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $1.6 million for Q2 2025, and $1.6 million during Q1 2025.